A critical assessment of the synthesis and biological activity of p53/human double minute 2-stapled peptide inhibitors.

Wallbrecher, Rike; Chène, Patrick; Ruetz, Stephan; Stachyra, Therese; Vorherr, Thomas; Brock, Roland

Wallbrecher, Rike; Chène, Patrick; Ruetz, Stephan; Stachyra, Therese; Vorherr, Thomas; Brock, Roland.

Affiliation

Wallbrecher R; Department of Biochemistry, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Chène P; Novartis Institutes for Biomedical Research, Basel, Switzerland.
Ruetz S; Novartis Institutes for Biomedical Research, Basel, Switzerland.
Stachyra T; Novartis Institutes for Biomedical Research, Basel, Switzerland.
Vorherr T; Novartis Institutes for Biomedical Research, Basel, Switzerland.
Brock R; Department of Biochemistry, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.

Br J Pharmacol ; 174(16): 2613-2622, 2017 Aug.

Article de En | MEDLINE | ID: mdl-28436014

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Peptides / Protéine p53 suppresseur de tumeur / Protéines proto-oncogènes c-mdm2 Limites: Humans Langue: En Journal: Br J Pharmacol Année: 2017 Type de document: Article Pays d'affiliation: Pays-Bas Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google